Scratching is a hardwired reflex triggered when nerve fibers in the skin detect an irritant and relay an itch signal to the brain. In healthy circumstances this serves a protective function, helping to dislodge insects or irritants before they cause harm. But when the itch becomes chronic, persisting for weeks or months with no obvious external trigger, the causes branch out far beyond mosquito bites or dry skin. Chronic itch can originate from the skin itself, from organ disease deep inside the body, from damaged nerves, from psychological stress, or even from the medications meant to treat other problems.
How Itch Signals Travel From Skin to Brain
Your skin is threaded with specialized nerve fibers whose sole job is detecting itch-provoking stimuli. Research has shown that at least two separate populations of these fibers exist. One set responds to histamine, the molecule behind a classic allergic itch. A different, non-overlapping set responds to other pruritogens like those found in cowhage (the tropical “itching bean”). Histamine activates one fiber type, while cowhage activates another entirely, yet both produce a similar sensation of itch.1PubMed Central. Separate peripheral pathways for pruritus in man This matters because it explains why antihistamines, which block only the histamine pathway, often fail to relieve chronic itch. If the itch is running through the other channel, blocking histamine does nothing.
Once those peripheral nerve fibers fire, the signal enters the spinal cord. A group of neurons in the dorsal horn uses a chemical messenger called gastrin-releasing peptide (GRP) to pass the itch signal upward to the brain.2PubMed Central. How Gastrin-Releasing Peptide Opens the Spinal Gate for Itch In animal experiments, removing these GRP-expressing neurons reduced scratching responses to multiple itch-provoking chemicals, while activating them produced itch-like behavior, and pain responses stayed unchanged.3Journal of Neuroscience. Dorsal Horn Gastrin-Releasing Peptide Expressing Neurons Transmit Spinal Itch But Not Pain Signals Interestingly, a separate study using a different genetic technique to ablate spinal GRP neurons found no significant change in itch behavior, suggesting the spinal wiring for itch has built-in redundancy and the picture is still being sorted out.4Nature Communications. Exploration of sensory and spinal neurons expressing gastrin-releasing peptide in itch and pain related behaviors
Why Scratching Feels So Good
Anyone who has ever scratched a persistent itch knows the rush of relief that follows. That relief is not just subjective. Brain imaging studies show that active scratching recruits the brain’s reward circuits, including the ventral tegmental area, a region central to the dopamine-based pleasure system.5PLOS ONE. Brain’s Reward Circuits Mediate Itch Relief. A Functional MRI Study of Active Scratching In people with chronic itch, the reward-system response to scratching is even more intense than in healthy controls, with greater activity in motor-planning and motivation areas of the brain. Researchers have suggested this heightened activity may contribute to an addictive quality to scratching in chronic itch patients.6PubMed. Scratching Induces Overactivity in Motor-Related Regions and Reward System in Chronic Itch Patients
Animal research paints the same picture from a different angle. In mice, scratching during both acute and chronic itch was shown to activate dopamine neurons in the ventral tegmental area and boost dopamine release in the nucleus accumbens, a key reward hub. When researchers chemically suppressed the dopamine pathway, the animals scratched less. The mice even showed a conditioned preference for the place where they had scratched, essentially treating the act of scratching as a reward in its own right.7PubMed. Direct evidence that the brain reward system is involved in the control of scratching behaviors induced by acute and chronic itch This reward-system hijacking helps explain why people with chronic conditions find it so hard to stop scratching even when they know it is making things worse.
The Itch-Scratch Trap
Scratching provides momentary relief because the mechanical stimulation triggers inhibitory signals in the spinal cord, temporarily quieting itch-transmitting neurons. Research in animals has shown that this inhibition depends on two chemical systems: glycine and GABA. When either was blocked in the spinal cord, scratching lost most of its ability to suppress itch-neuron firing.8PLoS ONE. Transmitters and Pathways Mediating Inhibition of Spinal Itch-Signaling Neurons by Scratching and Other Counterstimuli But the relief is short-lived. Scratching damages the skin barrier and triggers inflammation, which sensitizes nerve endings and lowers the threshold for the next itch signal. The cycle then escalates: itch leads to scratch, scratch leads to skin damage, damage leads to more itch.
This is one reason many chronic itch conditions feature thickened, roughened skin at the scratching site. The ongoing mechanical trauma can also introduce infection, further fueling inflammation. Breaking this cycle is a central goal of treatment for almost every form of chronic itch, whether the original trigger is in the skin, the organs, or the nerves.
Skin Conditions That Drive Chronic Itch
Atopic dermatitis (eczema) is one of the most common causes of chronic scratching. The condition involves a weakened skin barrier, partly because of reduced production of a structural protein called filaggrin, combined with an overactive immune response skewed toward a particular branch of immune cells. These cells produce inflammatory signaling molecules that make itch worse in two ways: they further weaken the barrier and they directly stimulate itch-sensing nerves.9Allergology International. Atopic dermatitis: immune deviation, barrier dysfunction, IgE autoreactivity and new therapies One of the most potent itch-driving molecules in eczema is interleukin-31, which is produced by immune cells in the inflamed skin and directly triggers scratching behavior when injected into animals.10PubMed. Emerging role of interleukin-31 and interleukin-31 receptor in pruritus in atopic dermatitis
Other skin diseases also produce severe chronic itch, including psoriasis, contact dermatitis, fungal infections, and a condition called prurigo nodularis, where persistent scratching leads to hard, intensely itchy nodules. Prurigo nodularis has become a focal point for new drug development, with two biologic medications now approved specifically for it.
When the Problem Is Not Your Skin
Some of the most maddening forms of chronic itch have nothing visibly wrong with the skin at all. The itch comes from inside the body, driven by organ disease or metabolic imbalance.
Liver Disease
Cholestatic liver diseases, where bile flow is obstructed, are notorious for causing unbearable itching. For years, bile salts were blamed, but more recent research points to a substance called lysophosphatidic acid (LPA) and the enzyme that produces it, autotaxin. In patients with cholestatic itch, autotaxin levels in the blood strongly correlate with itch intensity, more so than bile acid or opioid levels do.11Clinical Medicine. Drug treatment of pruritus in liver diseases Elevated autotaxin appears to be specific to cholestatic itch and is not found in itch caused by kidney disease, Hodgkin’s lymphoma, or eczema.12PubMed. Serum autotaxin is increased in pruritus of cholestasis, but not of other origin, and responds to therapeutic interventions In addition to LPA, endogenous opioids, bilirubin, and histamine accumulate in the blood and contribute to the itch through effects on skin nerves and the spinal cord.13PubMed Central. Pruritus in Chronic Cholestatic Liver Diseases, Especially in Primary Biliary Cholangitis: A Narrative Review
Kidney Disease
Chronic kidney disease produces a different but equally distressing itch. The mechanism involves a tug-of-war between two opioid receptor systems in the nervous system. One type (mu-opioid receptors) tends to promote itch, while the other (kappa-opioid receptors) tends to suppress it. In kidney disease, the balance tilts toward itch. Drugs that tip the balance back, like the kappa-opioid agonist difelikefalin, have shown meaningful reductions in itch severity in dialysis patients.14Clinical Kidney Journal. Unravelling the pathophysiology of chronic kidney disease-associated pruritus This opioid imbalance hypothesis is supported by the fact that common opioid pain medications (which stimulate mu receptors) are well known to cause itching as a side effect.15NefrologÃa (English Edition). Etiopathogenesis of chronic kidney disease-associated pruritus
Blood Disorders
Polycythemia vera, a condition where the bone marrow produces too many red blood cells, causes a distinctive form of itch in roughly 40% of patients. The hallmark is that the itch is triggered by contact with water at any temperature, a phenomenon called aquagenic pruritus. Stepping out of a shower can produce intense, prickling itchiness that lasts for minutes to an hour.16PubMed Central. Polycythemia vera-associated pruritus and its management This water-triggered itch pattern is unusual enough that some clinicians consider it a potential early clue to the diagnosis.
Neuropathic Itch From Nerve Damage
When the nerves that carry sensory information are themselves damaged or compressed, they can misfire and produce an itch sensation that has no external cause. This is neuropathic itch, and it can be deeply frustrating because there is nothing to treat on the skin surface.17PubMed Central. From Compression to Itch: Exploring the Link Between Nerve Compression and Neuropathic Pruritus It also commonly causes depression, sleep disruption, and social strain beyond the itch itself.
Two well-known examples are notalgia paresthetica, an itchy patch on the upper back caused by compression or irritation of thoracic spinal nerves, and brachioradial pruritus, an itch on the outer forearm linked to cervical spine nerve involvement.18PubMed. Notalgia Paresthetica: An Updated Review of Pathophysiology, Diagnosis, and Treatment Approaches These conditions often go undiagnosed for years because the skin looks normal and doctors focus on dermatologic causes. Shingles (herpes zoster) can also leave behind chronic neuropathic itch in the area where the rash occurred, sometimes persisting long after the rash has healed. Topical treatments generally provide minimal relief for neuropathic itch because the problem lives in the nerve, not at the skin surface. Treatments tend to focus on the nerve itself, with medications like gabapentin or capsaicin sometimes offering some benefit.
Stress, Anxiety, and Itching
If you have noticed that you itch more when you are stressed, anxious, or emotionally drained, you are not imagining it. Psychological stress activates the body’s stress-response systems, which in turn stimulate mast cells in the skin to release histamine and inflammatory neuropeptides like substance P and nerve growth factor.19Frontiers in Cellular Neuroscience. Mast Cells and Sensory Nerves Contribute to Neurogenic Inflammation and Pruritus in Chronic Skin Inflammation These molecules amplify inflammation and lower the threshold for itch signals. The effect is bidirectional, too: chronic itch causes poor sleep and psychological distress, which feeds back into the itch cycle.20Clinical Therapeutics. Why Do I Scratch Myself? Causes of Chronic Itching
This stress-itch connection is especially pronounced in conditions like eczema and psoriasis, where flares notoriously cluster around stressful life events. But stress can also generate itch in people with no underlying skin disease, a phenomenon sometimes grouped under the umbrella of psychogenic itch. In those cases, the itch is real and physiologically mediated; it is not “all in your head” in the dismissive sense, even though its origin is in the nervous system rather than the skin.
Medications That Cause Itching
A surprising number of drugs can provoke itch as a side effect, and the mechanism is not always a simple allergic reaction. A receptor on skin mast cells called MRGPRX2 has emerged as a key player. Unlike the classic allergic pathway, which requires prior sensitization by the immune system, MRGPRX2 can be triggered directly by certain drugs without any immune priming. This leads to mast cell degranulation (the release of histamine and other inflammatory mediators) that causes itch, redness, and sometimes reactions resembling anaphylaxis.21PubMed. MRGPRX2, drug pseudoallergies, inflammatory diseases, mechanisms and distinguishing MRGPRX2- and IgE/FcεRI-mediated events Drugs known to activate MRGPRX2 include certain muscle relaxants used during surgery, fluoroquinolone antibiotics, and some opioid pain medications.22PubMed Central. Therapeutic Potential of MRGPRX2 Inhibitors on Mast Cells Because the reaction does not involve antibodies, standard allergy testing comes back negative, which can confuse both patients and clinicians.
Opioids are a particularly common culprit. Beyond their MRGPRX2 activity in the skin, they also promote itch centrally through the mu-opioid receptor mechanism described earlier in the context of kidney disease. If you have ever experienced post-surgical itching or itch from codeine-containing medications, this is likely why.
Why Itching Gets Worse at Night
People with chronic itch commonly report that the sensation peaks in the evening and at night. Several factors converge. Skin temperature rises at night, and the skin’s barrier function fluctuates with the body’s circadian rhythm, both of which can amplify itch signals.23PubMed. Nocturnal itch: why do we itch at night? At the molecular level, cortisol (which has anti-inflammatory effects) drops to its lowest point in the late evening, while levels of certain inflammatory cytokines and prostaglandins rise. Melatonin release and core body temperature changes add to the mix. Researchers have found that clock genes in the skin and immune cells regulate inflammatory signaling pathways in a time-dependent manner, making the skin more itch-prone during the body’s natural rest period.24PubMed Central. Circadian rhythm of cutaneous pruritus
There is also a psychological component. During the day, mental activity and physical engagement compete for your attention. At night, with fewer distractions, the brain turns up the volume on sensory signals that were partially masked during waking hours. This is similar to how a ticking clock in the room seems louder once you are trying to sleep.
Aging and Itch
Chronic itch becomes more common with age, and the reasons stack up. The skin barrier weakens as you get older, producing less of the lipids and natural moisturizing factors that keep water in and irritants out. The immune system shifts in ways that make inflammatory responses less controlled. And age-related nerve changes, including small-fiber neuropathy, alter how itch signals are processed.25PubMed Central. Management of Itch in the Elderly: A Review Older adults are also more likely to be taking multiple medications, any of which could independently provoke itch. The net result is that many older people develop persistent itching that does not clearly belong to any single disease category and can be hard to treat with a one-size-fits-all approach.
Newer Treatments for Chronic Itch
Until recently, treatment options for severe chronic itch were limited to antihistamines (which fail in many itch types), corticosteroids, and a handful of sedating oral medications. The landscape has shifted considerably. Two biologic drugs are now approved for prurigo nodularis: dupilumab, which blocks signaling from interleukin-4 and interleukin-13, and nemolizumab, which targets the interleukin-31 receptor, the same itch-driving molecule discussed in the context of eczema. In clinical trials, roughly half to 60% of patients on dupilumab achieved a meaningful reduction in itch severity over 24 weeks, while nemolizumab showed a faster onset of itch relief, with improvements visible as early as four weeks.26PubMed Central. Comparison of Dupilumab and Nemolizumab for Prurigo Nodularis: FDA-Approved Biologic Therapy Selection Other approaches in the pipeline include JAK inhibitors and antibodies targeting additional immune pathways.27PubMed Central. Emerging Therapies in the Treatment of Prurigo Nodularis: Biological Therapy and Systematic Review of Literature
For kidney-disease itch specifically, difelikefalin (the kappa-opioid agonist) has been a meaningful advance for patients on hemodialysis whose itch did not respond to antihistamines or gabapentin.28PubMed Central. Successful Use of Difelikefalin in Severe Chronic Kidney Disease-Associated Pruritus in a Patient With Complex Etiological Contributors A meta-analysis of opioid-based and GABA-analog therapies for kidney-associated itch confirmed that opioid-receptor-targeting treatments significantly decreased itch scores, though they also came with higher rates of gastrointestinal and neurological side effects like sleep disturbance.29Kidney International Reports. Meta-Analysis of Randomized Controlled Trials on Gamma-Aminobutyric Acid Analogues and Opioid-Based Therapies for CKD-Associated Pruritus
On the behavioral side, habit reversal therapy, a structured approach that teaches patients to recognize the urge to scratch and substitute a competing response, has shown promise for reducing scratching and improving outcomes in eczema, particularly in children.30PubMed Central. Habit Reversal Therapy: An Underutilized Treatment for Atopic Dermatitis It works not by eliminating the itch but by disrupting the itch-scratch cycle before the scratching does its damage.
When Seeing Someone Scratch Makes You Itch
You have probably noticed that watching someone else scratch makes you want to scratch too, even when nothing is itching. This is contagious itch, and brain imaging confirms it is a real neurological phenomenon. When people watched video of someone scratching (compared with neutral tapping), the brain regions activated were the same ones involved in physically feeling itch, including the anterior insula and primary somatosensory cortex. The strength of activation correlated with how itchy participants rated themselves, and people who scored higher on neuroticism (a personality trait associated with greater emotional sensitivity) showed a stronger response.31PubMed Central. Neural basis of contagious itch and why some people are more prone to it
This finding fits with a broader picture of itch as partly a top-down phenomenon. The brain is not passively waiting for a signal from the skin; it is actively interpreting context, visual cues, and emotional state. That is why stress, attention, and even social observation can amplify itch. And it underscores the fact that for people living with chronic itch conditions, the experience involves the entire nervous system from skin to spinal cord to brain, not just a patch of irritated skin.
Itch as a Defense System
Stepping back from the pathology, itch exists for a reason. It is part of a highly conserved defense system that evolved to protect animals from harm. Just as pain from touching something hot warns you to pull away, itch warns you that something is on your skin that could be dangerous: a tick that carries disease, a toxic plant, or a parasite. The scratch reflex can dislodge an insect before it has time to transmit pathogens, and the inflammation that follows scratching recruits immune cells to the area to fight anything that got through.32Current Biology. Itch Chronic itch, then, can be thought of as this defense system stuck in overdrive, firing in the absence of the threats it was designed to detect, or firing in response to internal signals like inflammation, metabolic waste products, or nerve dysfunction that mimic those ancient threats.